Quantitative evaluation revealed markedly elevated RGC32 protein levels in DLBCL compared to benign lymphoid hyperplasia (Figure 1A), implicating its potential association with disease progression in this lymphoma subtype. This evidence concerns the gene RGCC and lymphoma.